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470Objective: We sought to examine the relationship between extracorporeal membrane oxygenation center case
volume and survival in pediatric patients requiring extracorporeal membrane oxygenation support.
Methods: Pediatric patients (20 years) undergoing extracorporeal membrane oxygenation cannulation were
identified using the Healthcare Cost andUtilization Project Kids’ Inpatient Database for 2000 to 2009. Annual hos-
pital extracorporealmembrane oxygenationvolume tertileswere<15 patients/year (low volume), 15 to 30 patients/
year (mediumvolume), and>30 patients/year (high volume). Cases of extracorporealmembrane oxygenationwere
segregated by indication into cardiac and noncardiac groups. Cases of cardiac extracorporeal membrane oxygena-
tion were mapped to Risk Adjustment for Congenital Heart Surgery categories to adjust for case complexity.
Weighted multivariable logistic and linear regression models identified determinants of in-hospital mortality.
Results: Overall, 3867 cases of extracorporeal membrane oxygenation were identified, yielding a national esti-
mate of 6333  495 cases. Extracorporeal membrane oxygenation was used with nearly equivalent prevalence
across volume tertiles for all Risk Adjustment for Congenital Heart Surgery categories, suggesting that patient se-
lection for extracorporeal membrane oxygenation was fairly uniform. A higher annual extracorporeal membrane
oxygenation volume tertile was associated with reduced in-hospital mortality (P ¼ .01) within nearly all Risk
Adjustment for Congenital Heart Surgery categories. After adjustment for Risk Adjustment for Congenital Heart
Surgery category and other patient variables, lower extracorporeal membrane oxygenation volume remained an
important determinant of in-hospital death (odds ratio, 1.75; 95% confidence interval, 1.03-2.94; P ¼ .03).
Conclusions: Higher extracorporeal membrane oxygenation case volume is associated with improved hospital
survival in pediatric cardiac extracorporeal membrane oxygenation patients. The results of this study may sup-
port the paradigm of regionalized centers of excellence for managing pediatric cardiac extracorporeal membrane
oxygenation patients. (J Thorac Cardiovasc Surg 2013;145:470-5)Earn CME credits at
http://cme.ctsnetjournals.org
In general, evidence supports a beneficial impact of institu-
tional surgical case volume on in-hospital mortality and re-
source use in congenital cardiothoracic surgery.1-7 Despite
the comparably high mortality and cost inherent in the pro-
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The Journal of Thoracic and Cardiovascular Surgsupport, the relationship between center case volume and
these outcomes within the context of pediatric ECMO
have not been characterized. Investigation of institutional
variables, including annual case volume, that modulate out-
comes for pediatric ECMO has been limited for 3 main rea-
sons: (1) ECMO is used in a diverse group of patients with
divergent indications; (2) it is managed by different clinical
providers (general surgeons vs cardiac surgeons) depending
on institution precedent and diagnostic indication; and (3)
the threshold for implementation, which may be an impor-
tant determinant of outcome, is often dependent on individ-
ual provider and/or institutional bias. Despite these inherent
limitations, however, it is probable that data from this het-
erogeneous population can be synthesized to estimate the
impact of institutional factors. Enhanced understanding of
whether institutional volume improves ECMO outcomes
is important because the wisdom of extending regionaliza-
tion initiatives to the provision of ECMO support requires
evidence that such mandates would improve results. The
current study evaluates whether annual institutional
ECMO case volume influences in-hospital mortality among
pediatric patients requiring ECMO.ery c February 2013
Abbreviations and Acronyms
ECMO ¼ extracorporeal membrane oxygenation
KID ¼ Kids’ Inpatient Database
PHIS ¼ Pediatric Health Information Systems
RACHS ¼ Risk Adjustment for Congenital Heart
Surgery
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Patients and Data Set
This study was designed as a retrospective cohort analysis using the
Healthcare Cost and Utilization Project Kids’ Inpatient Database (KID)
(years 2000, 2003, 2006, and 2009). Pediatric patients (age 20 years)
who received ECMO support were identified using the International Classi-
fication of Diseases, Ninth Revision, Clinical Modification code 39.65. The
KID is an administrative all-payer, pediatric, inpatient care database in the
United States. For each year, the database contains data from between 2.5
to 3.4 million discharges for patients20 years of age, representing a strat-
ified sampling of pediatric discharges from 2784 (2000), 3438 (2003), 3739
(2006), and 4121 (2009) U.S. community hospitals in 27 (2000), 36 (2003),
38 (2006), and 44 (2009) states.8,9 Systematic random sampling was used to
select 10% of uncomplicated and 80% of complicated births. National
estimates provided in the KID are calculated using discharge weights
based upon the American Heart Association universe, and vary by year.
The methodology for calculating the discharge weights and estimates for
the KID are complex, but have been validated extensively. Detailed
information regarding their calculation can be found at their Web site
(http://www.hcup-us.ahrq.gov/db/nation/kid/KID_2009_Introduction.pdf).
Briefly, discharge weights are calculated for KID data by stratifying the
hospitals on the same variables that were used for creating the sample and
then creating weights by stratum. The stratifying variables are geographic
region, urban/rural location, teaching status, bed size, ownership, and
children’s hospital. The KID contains more than 100 clinical and nonclinical
variables, and has been used by our group5,10,11 and others12,13 to study rare
conditions such as congenital heart disease and procedures such as pediatric
mechanical assist devices. Institutional review board approval was obtained
for this study. All authors signed the KID Data Use Agreement as required.
Hospitals and Cases
Annual hospital ECMO volume was analyzed as a continuous variable,
with subsequent segregation into ECMO volume tertiles (<15 cases/year,
low volume; 15-30 cases/year, medium volume; >30 cases/year, high
volume). Because the KID uses only 80% of complicated births, ECMO
volumes were then multiplied by a factor of 1.25 (0.80 3 1.25 ¼ 100).
Sampling weights provided by the KID were used to calculate national
estimates. Associated diagnosis codes were used to segregate ECMO cases
by indication into primary cardiac or noncardiac. Cardiac cases were map-
ped to Risk Adjustment for Congenital Heart Surgery (RACHS) cate-
gories14 to provide adjustment for case complexity. Timing of ECMO
deployment was calculated based on the difference between the date of
admission and the date on which ECMO occurred.
Statistical Analysis
Data are reported as medians with ranges or means with standard devi-
ation depending on normality. Categorical variables were compared with
the Rao-Scott c2 test, and continuous variables were compared using
a 2-sided t test. Statistical significance was set at a P value.05. Weighted
multivariable logistic and linear regression models accounting for the strat-
ified sampling scheme of the KID (PROC SURVEY) identified determi-
nants of in-hospital mortality. A priori variables tested included patient
factors such as age, gender, and ECMO indication, and hospital factorsThe Journal of Thoracic and Casuch as whether the hospital was a teaching hospital, bed size, and volume.
Calendar year was included in all multivariablemodels to account for a pos-
sible era effect. Interactions were not evaluated. SAS software version 9.2
(SAS, Cary, NC) was used for all analyses.RESULTS
Patients and Hospitals
We identified 3867 ECMO cases, yielding a national
estimate of 6333 495 ECMO cases. Cardiac ECMO cases
predominated, with 593  97 (10%) noncardiac cases and
5740  487 (90%) cardiac cases overall. The majority
of ECMO cases (n ¼ 4662  354; 2190  278
[low] þ 2471  327 [medium]) occurred at either 145
low-volume hospitals or at 46 medium-volume hospitals,
with only 1672  423 cases performed at 16 high-volume
hospitals. Patient characteristics were similar among the 3
volume groups, with the exception that high-volume
ECMO centers performed a significantly higher proportion
of cardiac ECMO cannulations (Table 1).
The mean time to ECMO deployment overall was
6.7  0.43 days, and did not differ among the volume ter-
tiles (P ¼ .74). Mean time to deployment was 6.5 days
for low-volume centers, 6.9 days for medium-volume
centers, and 6.9 days for high-volume centers.
Figure 1 demonstrates the case-complexity distribution
of cardiac ECMO cases. Overall, 4954 of the 5740 cases
(86%) were able to be mapped to a RACHS category.
Among cardiac ECMO cases, the majority of ECMO cases
(n ¼ 3277) occurred in medium-complexity categories
(RACHS-3 and -4 levels), which include patients who un-
dergo surgical procedures such as arterial switch operation
without ventricular septal defect, and complete repair of
atrioventricular septal defect.In-Hospital Mortality
Overall risk-unadjusted mortality was higher for cardiac
ECMO compared with noncardiac ECMO (2660  223
(46%) vs 230  43 (39%), respectively; P ¼ .03).
Figure 2 demonstrates risk-unadjusted in-hospital mortality
segregated by ECMO volume tertile and indication. When
segregated by volume tertile, low-ECMO volume hospitals
had significantly higher in-hospital mortality compared
with high-ECMO volume hospitals (918  90 (49%) vs
691  179 (43%), respectively; P ¼ .015). However,
when including medium-ECMO volume hospitals, which
had intermediate mortality, there was still a strong trend
suggesting lower volumewas related to increased mortality,
but statistical significance was not reached (P¼ .08). There
was no discernible relationship between ECMO case vol-
ume and mortality for noncardiac ECMO (P ¼ .21).
Case-complexity distribution among ECMO volume ter-
tiles was remarkably similar, suggesting that individual cen-
ters are using ECMO with equivalent frequency in most
RACHS-complexity categories (P ¼ .84; Figure 3, A).rdiovascular Surgery c Volume 145, Number 2 471
TABLE 1. Patient characteristics segregated by volume categories
Variable Low Medium High
P
value
Age, year; mean
(SD)
1.9 (4.7) 1.5 (4.1) 1.3 (3.6) NS
Female,%; NE
(SE)
43; 1233 (103) 44; 1351 (182) 44; 942 (233) NS
Race,%* NS
Caucasian 46 50 53
Asian 21 18 15
Black 19 15 16
Hispanic 3 4 2
Native American 1 1 <1
Other 10 12 14
Cardiac ECMO,
%; NE (SE)
86; 1877 (172) 91; 2237 (305) 97; 1626 (414) .005
Hospital length
of stay, days;
median (range)
24 (0-317) 29 (0-294) 29 (0-332)
SD, Standard deviation; NS, not significant; NE, national estimate; SE, standard error;
ECMO, extracorporeal membrane oxygenation. *Reporting of nonpercentages for
categories that may have<10 discharges is not permitted.
FIGURE 2. Risk-unadjusted in-hospital extracorporeal membrane oxy-
genation (ECMO) mortality segregated by ECMO volume group tertile
and indication. Note that mortality for cardiac ECMO is higher than for
noncardiac ECMO. Percentages at the top indicate the mortality within
each ECMO volume group. Low-volume hospitals have significantly
higher mortality among cases of cardiac ECMO compared with high-
volume hospitals (P ¼ .015). For noncardiac ECMO, the same trend
applies, but statistical significance was not reached.
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DHowever, within nearly all RACHS categories, there was
a trend toward lower mortality in high-volume centers, al-
though statistical significance was reached only within
RACHS category 2 (Figure 3, B). For example, in the high-
est complexity, RACHS category 6, which includes repair
of hypoplastic left heart syndrome, the prevalence of death
is 29% at high-volume centers compared with 43% at low-
volume centers.Independent Factors Associated With In-Hospital
Mortality
Multivariable patient factors associated with a reduction
in the risk of in-hospital death are shown in Table 2. PatientFIGURE 1. Cases of cardiac extracorporeal membrane oxygenation
(ECMO) cases segregated by Risk Adjustment for Congenital Heart Sur-
gery (RACHS)-1 category. As expected, the majority of cases fall within
the RACHS-3 or -4 levels, which are the most commonly performed pedi-
atric cardiac operations. The numbers accompanying each division of the
pie chart represent the percent of cases within each category and the
national estimates with their respective standard errors.
472 The Journal of Thoracic and Cardiovascular Surgvariables associated with improved survival included older
age and assignment to RACHS category 3. After adjustment
for patient factors and case complexity, high-volume
ECMO centers had significantly lower in-hospital mortality
compared with low-volume centers, with a reduction of ap-
proximately 50% in the odds of death. Interestingly, no in-
dependent influence of time was observed, indicating a lack
of era-specific improvement in ECMO mortality.DISCUSSION
We have shown, using a large national data set, that
higher annual ECMO volume is an important determinant
of improved in-hospital survival for pediatric patients re-
quiring ECMO support. We are aware of only 1 other study
that investigated the influence of hospital volume on ECMO
survival.15 Jen and Shew15 used the California Patient Dis-
charge Database to study 188 children (age 1 month-18
years) undergoing ECMO from 1999 to 2006. They found
a 1.34 times greater likelihood of survival with each stan-
dard deviation increase above a mean of 14 ECMO cases
per year. Increasing hospital volume, as pointed out by pre-
vious studies,1-5,10,11 is likely a surrogate for other hospital
characteristics (monetary resources, comprehensive array
of diagnostic tools and personnel, and an experienced
ECMO team) that contribute to improved outcomes.
However, these variables are more difficult to measure
accurately, lack objectivity, and are not captured with
reasonable fidelity in available national data sets.
We also found an important dichotomy based on ECMO
indication, in that mortality benefit of high-volume centers
appears to be restricted to pediatric patients requiring
cardiac ECMO. This dichotomy may have important
implications regarding potential ECMO and pediatricery c February 2013
FIGURE 3. A, Colored histograms depict the percent of annual cardiac
cases of extracorporeal membrane oxygenation (ECMO) within each
Risk Adjustment for Congenital Heart Surgery (RACHS)-1 category segre-
gated by center volume tertile. There were no differences among center
volume tertiles regarding the prevalence of ECMOwithin each complexity
category, indicating that centers use cardiac ECMO similarly across the
case complexity spectrum (P¼ .84). B, Colored histograms depict the per-
cent mortality for cases of cardiac ECMO within each RACHS-1 category.
Note that for nearly every category, there was a trend toward lower mortal-
ity for high-volume ECMO centers compared with low volume ECMO
centers, although statistical significance was reached only in cases in the
RACHS-2 category. For RACHS-6, which includes repair of hypoplastic
left heart syndrome, mortality in low-volume centers was 43% compared
with 29% in high volume centers. Note that the wide variation in the
RACHS-5 category is a result of the paucity of cases mapped to this cate-
gory (n ¼ 64). *P<.001.
TABLE 2. Multivariable model for in-hospital mortality
Variable OR 95% CI P value
Older age 1.03 1.01-1.05 .005
Year
2000 Reference
2003 1.16 0.85-1.58 .35
2006 1.26 0.94-1.68 .12
2009 1.10 0.83-1.46 .52
Volume group
Low volume Reference
Medium volume 0.78 0.59-1.01 .06
High volume 0.51 0.30-0.87 .01
RACHS category
RACHS 1 0.67 0.23-1.92 .46
RACHS 2 0.82 0.63-1.07 .14
RACHS 3 0.78 0.64-0.96 .02
RACHS 4 0.94 0.75-1.19 .63
RACHS 5 1.32 0.77-2.23 .32
RACHS 6 Reference
Model fit: C statistic¼ 0.6.OR,Odds ratio;CI, confidence interval; RACHS,Risk Ad-
justment for Congenital Heart Surgery.
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Dcardiac surgery regionalization initiatives.1,7,16 Although
previous data regarding the impact of volume on
outcomes in pediatric cardiac surgery are not conclusive
and often inconsistent,3-5,17,18 and we have argued
previously4,17,19-21 that volume as an isolated variable is
a rather poor discriminatory metric, there is a growing
body of evidence that mortality following pediatric
cardiac surgery is inversely proportional to both annual
institutional and surgeon volume.1-6,13 Based on these
data, several authors have proposed that high-complexity
pediatric cardiac surgery should be performed at high-
volume centers to improve outcomes.2-7 Although weThe Journal of Thoracic and Cafound that ECMO support was used with equivalent
frequency in all RACHS categories across the spectrum of
volume tertiles, high-volume centers performed better
than low-volume centers in nearly all complexity cate-
gories. The results of this study suggest, therefore, that the
provision of cardiac ECMO support should be considered
when planning broader regionalization initiatives for com-
plex pediatric cardiac surgery. Regionalization of care,
however, must be balanced in terms of limiting access to
care and requiring the transfer of critically ill patients,
which may lead to adverse outcomes. More important, al-
though we cannot explain directly the reason that high-
volume centers had dramatically reduced mortality among
ECMO cases in RACHS category 2, this finding does under-
score the notion that even conceptually simple cases can
have unexpected outcomes, and that in these cases,
ECMO can be a life-saving therapy. Further studies are nec-
essary to determine the feasibility, impact, and ideal struc-
tural design of regionalization in congenital cardiac surgery.
There are multiple reasons why high-volume centers may
have improved results with cardiac ECMO. Earlier timing of
ECMO deployment has been recommended by others.22,23
Preemptive use of ECMO may lead to more favorable
clinical patient status, before the onset of multisystem
organ failure, and could also lead to more favorable
circumstances surrounding cannulation. We did not find any
difference in ECMO deployment among volume tertiles,
although we were constrained by the necessity to use date
of admission as time 0 because our data set was constructed
by using ECMO as the index procedure. In some cases,
ECMO deployment could, conceivably, be better calculated
based on an alternate reference point (ie, the time from
another index procedure). Unfortunately, we could notrdiovascular Surgery c Volume 145, Number 2 473
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Dascertain the patient’s clinical condition at the time of ECMO
deployment from the current data set, but differences in
illness severity certainly may have contributed to our results.
We were surprised by the paucity of noncardiac ECMO
cases found in the KID. Based on extracorporeal life support
organization registry data (2000-2009), there were approxi-
mately 6181 cardiac ECMO cases and 9597 noncardiac
ECMO cases in a contemporaneous period.24 The basis for
this discrepancy is poorly understood, but the difference is
consistent with data reported in a previous study15 that also
used an administrative data set in which respiratory failure
accounted for only 12% of the total ECMO cases. Cardiac
case allocation in our current study was assigned initially
by identification of those cases that mapped to discrete
RACHS categories (indicating the presence of a cardiac sur-
gical procedure during the index hospitalization), and was
verified subsequently by cross-checking individual diagno-
sis codes for a 30% sample ofmapped cases and all nonmap-
ped cases. It is possible that noncardiac ECMO cases are not
captured with equal fidelity in administrative data sets, con-
sidering that such data sets are designed for claims collection
and billing and therefore may be biased in favor of recording
cases in which a cardiac surgical procedure was performed.
Study Limitations
Our data were obtained retrospectively from a large ad-
ministrative data set. Missing data or miscoded data are po-
tential sources of bias that cannot be excluded. However, the
large sample size used in our study minimizes the impact
of individual coding errors. The KID is also an incomplete
(80%) sample of complicated hospital discharges. However,
its sampling algorithm used has been validated extensively
and shown to provide accurate and robust national estimates
in categories for which sufficient data exist. We attempted to
account for the 80% sample by multiplying annual ECMO
case volumes by 1.25. Case-complexity assignment in this
study used the RACHS methodology. Although more recent
iterations (Society of Thoracic Surgeons-European Asso-
ciation of Cardiothoracic Surgeons Mortality category,
Aristotle score)25,26 for determining risk adjustment are
available, RACHS was chosen for our analysis because it
was designed and validated for use with administrative
data.14 In addition, our group has used this mapping algo-
rithm with both the KID and the Nationwide Inpatient
Sample in several previously published studies.1,4,5,10,11,17
The categorization of ECMO volume tertiles was somewhat
arbitrary. However, volume tertiles were optimized from the
raw data to be analytically pragmatic, given the polarity of
volume distribution with very few centers performing high
ECMO case volumes.
It is plausible that specific improvements may have been
distributed unequally across volume categories (ie, higher
volume centers may have adopted newer technologies ear-
lier). Although we cannot exclude the possibility of such474 The Journal of Thoracic and Cardiovascular Surgan era effect, we did use calendar year to account for
changes in management and technology during the study
period. Last, we were not able to determine the duration
of ECMO or the clinical circumstances surrounding cannu-
lation. These issues are critical components of outcome ac-
cording to recent reports22,23 and may have influenced our
results.
Although other administrative databases exist, such as
the Pediatric Health Information Systems (PHIS) database,
these databases have limited participation from selected
hospitals that could increase informative bias and limit
our ability to capture low-volume centers. The PHIS data-
base currently has only 41 participating hospitals across
the United States, with essentially no participants from
the central United States. The PHIS database could be ideal
for analyzing longitudinal outcomes associated with ECMO
use, including readmission and reintervention.CONCLUSIONS
Higher annual center ECMO case volume is associated
with improved hospital survival in pediatric cardiac
ECMO patients. Annual ECMO case volume is an indepen-
dent predictor of cardiac ECMO survival even when
comparing patients of similar clinical complexity. Region-
alization of care, in which the majority of cardiac ECMO
support is concentrated in large, high-volume centers, could
be considered a means of reducing resource use and
improving in-hospital survival.References
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